BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Isaacs D, Abdelaziz N, Keller M, Tibble J, Haq I. Measuring the response of extrahepatic symptoms and quality of life to antiviral treatment in patients with hepatitis C. Hepat Res Treat 2013;2013:910519. [PMID: 24223303 DOI: 10.1155/2013/910519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Whiteley D, Elliott L, Cunningham-burley S, Whittaker A. Health-Related Quality of Life for individuals with hepatitis C: A narrative review. International Journal of Drug Policy 2015;26:936-49. [DOI: 10.1016/j.drugpo.2015.04.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
2 Gill K, Ghazinian H, Manch R, Gish R. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int. 2016;10:415-423. [PMID: 26660706 DOI: 10.1007/s12072-015-9684-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 11.0] [Reference Citation Analysis]
3 Shahin AA, Zayed HS, Said M, Amer SA. Efficacy and safety of sofosbuvir-based, interferon-free therapy : The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C virus infection. Z Rheumatol 2018;77:621-8. [PMID: 28795238 DOI: 10.1007/s00393-017-0356-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]